Comment on: Martelletti et al. Refractory chronic migraine: a consensus statement on clinical definition from the European Headache Federation by unknown
Wöber and Wessely The Journal of Headache and Pain 2014, 15:77
http://www.thejournalofheadacheandpain.com/content/15/1/77LETTER TO THE EDITOR Open AccessComment on: Martelletti et al. Refractory chronic
migraine: a consensus statement on clinical
definition from the European Headache
Federation
Christian Wöber1*†, Peter Wessely2† and on behalf of the Austrian Consensus Group on Refractory Chronic
MigraineAbstract
In this letter, we present the Austrian proposal for diagnostic criteria of refractory chronic migraine and we
discuss the consensensus statement of the European Headache Feaderation. We focus in particular on the
definition of adequate prophylactic treatment, the management of medication overuse and the requirement for
CSF analyses in patients with refractory chronic migraine. In our proposal, the criteria for adequate treatment and
recommendations for dealing with medication overuse are more explicit than in the EHF proposal, whereas the
requirements for CSF analyses and measurement of CSF pressure are not as strict.Correspondence/Findings
We read with great interest the consensus statement on
refractory chronic migraine (rCM) from the European
Headache Federation (EHF) [1]. In parallel to EHF, a
group of neurologists experienced in the management of
chronic migraine (CM) as well as neurosurgeons and
anaesthesiologists with expertise in neuromodulation
prepared a consensus statement on rCM and patient se-
lection for occipital nerve stimulation (ONS) for Austria
[2]. We focused on ONS, since it is currently the only
neuromodulation technique for rCM examined in ran-
domized controlled studies [3-5].
In this comment we want to present the Austrian pro-
posal for diagnostic criteria of rCM, suggest revisions of
the “notes” in the EHF statement, summarize our rec-
ommendations for selecting ONS candidates and discuss
critical issues of rCM diagnostic criteria.
Diagnostic criteria
(A) CM according to ICHD-3-beta for at least 24 months
causing significant impairment of quality of life and/or* Correspondence: christian.woeber@meduniwien.ac.at
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reproduction in any medium, provided the origsocio-economic burden. (B) Modification of trigger factors
and lifestyle and treatment of comorbid disorders did not
improve the headache. (C) At least 3 adequate treatments
with prophylactic medication were unsuccessful. (1) “Un-
successful“ is defined by (a) no or insufficient efficacy
(based on patient report and recordings in a headache
diary), (b) intolerable adverse effects, (c) contraindications.
(2) Adequate treatment requires the intake of specific com-
pounds (a) from certain classes of drugs, (b) in an effective
dosage, (c) over a period of at least free months. (3) Classes
of drugs (a) beta blockers: propranolol 80-160 mg, meto-
prolol 100-200 mg, bisoprolol 5-10 mg, (b) anticonvulsants:
topiramate 75-100 mg, valproic acid 600-1500 mg (c) tricy-
clics: amitriptyline up to 75 mg, (d) flunarizine: 5–10 mg,
(e) other drugs with at least one positive randomised con-
trolled study - e.g. lisinopril 20 mg, candesartan 20 mg,
onabotulinumtoxin A 155 – 195U according to PREEMPT.
(4) Use of drugs from at least three of the classes a-d [6,7].Notes
(1) In patients with medication overuse (MO) according
to ICHD-3 beta, outpatient or inpatient detoxification and
diagnostic re-evaluation after two months of follow-up is
mandatory. (2) Other primary headaches such as hemicra-
nia continua and new daily persistent headache as well asThis is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
inal work is properly credited.
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headache must be excluded by history, clinical examin-
ation and laboratory analyses. (3) Cranial MRI including
the cranio-cervical region, MR-angiography and MR-
venography do not show a disorder explaining the head-
ache. (4) CSF pressure should be measured in patients
with evidence of sinus stenosis in MR venography [1].
Recommendations
Patient selection and management before ONS should
comprise confirmation of refractory CM and exclusion of
ONS contraindications, detoxification in case MO, pa-
tient information about ONS, exclusion of disorders
explaining the headache or preventing ONS, and detailed
written documentation (modified according to [8]).
Discussion
In rCM, there are two crucial points. First, adequate
prophylactic treatment of migraine and second, co-
existing MO. With respect to pharmaco-prophylaxis we
tried to be as specific as possible. In contrast to the EHF
criteria [1] requiring “at least 3 different drugs from the
following classes” and thus allowing diagnosis of rCM for
example after non-response to three different betablock-
ers, we think that the use of drugs from different classes
should be mandatory [2,6]. Furthermore, we specified the
required minimum dose for almost all prophylactic drugs
and did not just give a maximum dose as EHF did.
Regarding MO in CM there are four possible scenar-
ios, (1) no previous or current MO, (2) previous but no
current MO, (3) current without previous MO and (4)
previous as well as current MO. We believe that none of
these scenarios should a priori prevent the diagnosis of
rCM or subsequently the selection for invasive neuro-
modulation. In parallel to the ICHD-3 beta criteria of
CM, patients with rCM and MO could initially have
both diagnoses before the response to detoxification
allows confirming or rescinding the diagnosis of MO [9].
In our opinion, the EHF proposal is inconsistent with re-
spect to MO, since criterion A requires no MO, but recom-
mendations for detoxification are given in the “notes”. In
addition, we believe that a follow-up period after detoxifica-
tion should be specified. We also want to comment on CSF
analysis and measurement of CSF pressure. The “notes”
given by EHF suggest that CSF analyses are mandatory in
all patients with rCM. We think, this is not justified. The
same is true for the measurement of CSF pressure. The
possible importance of intracranial hypertension in patients
with “unresponsive chronic migraine” has only been sug-
gested in one single case series of 44 patients [10]. Further
studies are necessary to confirm these findings. For the time
being, measurement of CSF pressure may be performed
selectively in CM patients with abnormal findings in MR
venography, but not routinely in all patients with CM.Conclusion
Diagnostic criteria for rCM and guidelines for managing
patients with rCM and selecting candidates for invasive
neuromodulation are crucial issues. This comment may
contribute to the ongoing discussion promoted substan-
tially by the EHF consensus statement.
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